Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin: 2017-2025

Historic FCF Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to 0.56%.

  • Organogenesis Holdings' FCF Margin fell 476.00% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.10%, marking a year-over-year decrease of 1196.00%. This contributed to the annual value of 0.87% for FY2024, which is 65.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its FCF Margin stood at 0.56% for Q3 2025, which was up 101.55% from -36.15% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' FCF Margin registered a high of 10.67% during Q2 2021, and its lowest value of -36.15% during Q2 2025.
  • For the 3-year period, Organogenesis Holdings' FCF Margin averaged around -4.92%, with its median value being 0.98% (2023).
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 2,877bps in 2021, then slumped by 3,834bps in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' FCF Margin stood at 9.95% in 2021, then plummeted by 1,242bps to -2.47% in 2022, then surged by 979bps to 7.32% in 2023, then plummeted by 133bps to 5.98% in 2024, then plummeted by 476bps to 0.56% in 2025.
  • Its last three reported values are 0.56% in Q3 2025, -36.15% for Q2 2025, and -27.18% during Q1 2025.